US Stock MarketDetailed Quotes

Theravance Biopharma (TBPH)

Watchlist
  • 16.790
  • +0.050+0.30%
Close May 1 16:00 ET
  • 16.790
  • 0.0000.00%
Post 16:10 ET
864.94MMarket Cap8.15P/E (TTM)

Theravance Biopharma (TBPH) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
256.94%315.36M
256.94%315.36M
260.85%329.68M
252.63%338.8M
30.89%130.86M
-13.74%88.35M
-13.74%88.35M
-31.82%91.36M
-42.62%96.08M
-58.56%99.98M
-Cash and cash equivalents
343.97%167.81M
343.97%167.81M
647.60%174.77M
508.32%281.93M
105.47%110.61M
-4.42%37.8M
-4.42%37.8M
-67.39%23.38M
-56.11%46.35M
-71.31%53.84M
-Short-term investments
191.87%147.55M
191.87%147.55M
127.86%154.91M
14.36%56.88M
-56.13%20.24M
-19.61%50.55M
-19.61%50.55M
9.09%67.98M
-19.60%49.73M
-13.91%46.14M
Receivables
39.60%95.54M
39.60%95.54M
8.44%18.27M
53.29%21.92M
4.70%15.35M
291.67%68.44M
291.67%68.44M
-1.24%16.85M
-9.48%14.3M
19.51%14.66M
-Accounts receivable
146.96%45.54M
146.96%45.54M
8.44%18.27M
53.29%21.92M
4.70%15.35M
5.53%18.44M
5.53%18.44M
-1.24%16.85M
-9.48%14.3M
19.51%14.66M
-Other receivables
0.00%50M
0.00%50M
----
----
----
--50M
--50M
----
----
----
Prepaid assets
----
----
----
----
----
-96.42%73K
-96.42%73K
-63.46%597K
170.28%2.65M
36.88%2.09M
Other current assets
76.85%7.56M
76.85%7.56M
-12.08%6.75M
-11.35%5.57M
-46.41%4.06M
-63.14%4.28M
-63.14%4.28M
-14.66%7.68M
-19.20%6.28M
20.51%7.57M
Total current assets
159.80%418.46M
159.80%418.46M
204.51%354.7M
207.02%366.29M
20.89%150.26M
20.61%161.07M
20.61%161.07M
-27.96%116.48M
-37.86%119.31M
-52.44%124.29M
Non current assets
Net PPE
-15.39%30.27M
-15.39%30.27M
-14.59%31.71M
-17.08%33.13M
-21.83%34.46M
-21.13%35.77M
-21.13%35.77M
-20.79%37.12M
-16.77%39.96M
-14.08%44.08M
-Gross PPE
-7.02%54.09M
-7.02%54.09M
-14.59%31.71M
-17.08%33.13M
-21.83%34.46M
-13.09%58.17M
-13.09%58.17M
-20.79%37.12M
-16.77%39.96M
-14.08%44.08M
-Accumulated depreciation
-6.34%-23.82M
-6.34%-23.82M
----
----
----
-3.79%-22.4M
-3.79%-22.4M
----
----
----
Investments and advances
--11.13M
--11.13M
--3.03M
----
----
--0
--0
----
----
----
Other non current assets
-83.65%25.72M
-83.65%25.72M
-87.15%26.03M
-86.88%26.61M
-21.72%158.86M
-22.54%157.32M
-22.54%157.32M
-1.24%202.5M
-1.87%202.77M
-2.03%202.93M
Total non current assets
-65.24%67.11M
-65.24%67.11M
-74.64%60.76M
-75.39%59.74M
-21.74%193.32M
-22.28%193.09M
-22.28%193.09M
-4.87%239.63M
-4.68%242.72M
-10.89%247.01M
Total assets
37.10%485.57M
37.10%485.57M
16.67%415.46M
17.68%426.04M
-7.47%343.58M
-7.29%354.16M
-7.29%354.16M
-13.90%356.11M
-18.94%362.03M
-31.05%371.31M
Liabilities
Current liabilities
Payables
-2.96%7.86M
-2.96%7.86M
-20.86%6.29M
247.51%28.37M
1.04%8.26M
1.01%8.1M
1.01%8.1M
235.47%7.94M
420.33%8.16M
207.02%8.18M
-accounts payable
14.54%2.57M
14.54%2.57M
52.20%2.21M
0.06%1.68M
42.82%2.41M
47.11%2.24M
47.11%2.24M
-38.60%1.45M
6.69%1.67M
-36.69%1.69M
-Total tax payable
-9.67%5.29M
-9.67%5.29M
--4.07M
--26.7M
--5.85M
--5.85M
--5.85M
----
----
----
-Other payable
----
----
----
----
----
----
----
--6.49M
--6.49M
--6.49M
Current accrued expenses
46.87%19.5M
46.87%19.5M
78.89%20.21M
45.47%15.37M
31.95%12.43M
3.49%13.28M
3.49%13.28M
-14.84%11.3M
-23.42%10.56M
-41.35%9.42M
Current debt and capital lease obligation
2.18%10.95M
2.18%10.95M
160.10%10.91M
158.26%10.9M
165.99%10.81M
173.06%10.71M
173.06%10.71M
-56.80%4.2M
-53.94%4.22M
-45.32%4.06M
-Current capital lease obligation
2.18%10.95M
2.18%10.95M
160.10%10.91M
158.26%10.9M
165.99%10.81M
173.06%10.71M
173.06%10.71M
-56.80%4.2M
-53.94%4.22M
-45.32%4.06M
Current liabilities
19.38%38.3M
19.38%38.3M
59.62%37.41M
138.09%54.63M
45.43%31.5M
29.55%32.09M
29.55%32.09M
-7.62%23.44M
-6.52%22.95M
-17.27%21.66M
Non current liabilities
Long term debt and capital lease obligation
-18.79%31.76M
-18.79%31.76M
-17.42%33.68M
-16.21%35.56M
-14.81%37.35M
-13.55%39.11M
-13.55%39.11M
-0.81%40.79M
-0.19%42.44M
0.18%43.84M
-Long term capital lease obligation
-18.79%31.76M
-18.79%31.76M
-17.42%33.68M
-16.21%35.56M
-14.81%37.35M
-13.55%39.11M
-13.55%39.11M
-0.81%40.79M
-0.19%42.44M
0.18%43.84M
Other non current liabilities
2.74%33.11M
2.74%33.11M
-6.18%32.53M
-2.23%33.19M
-4.72%32.26M
-4.40%32.22M
-4.40%32.22M
-0.51%34.67M
-0.84%33.95M
0.58%33.86M
Total non current liabilities
2.74%150.55M
2.74%150.55M
-1.12%145.37M
0.80%146.55M
0.91%146.1M
1.59%146.53M
1.59%146.53M
3.47%147.02M
2.45%145.39M
2.09%144.78M
Total liabilities
5.73%188.85M
5.73%188.85M
7.23%182.78M
19.51%201.19M
6.71%177.6M
5.69%178.62M
5.69%178.62M
1.79%170.45M
1.12%168.34M
-0.92%166.44M
Shareholders'equity
Share capital
--1K
--1K
--1K
--1K
--1K
--0
--0
--0
--0
--0
-common stock
--1K
--1K
--1K
--1K
--1K
--0
--0
--0
--0
--0
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
10.97%-859.63M
10.97%-859.63M
3.09%-920.65M
1.39%-924.27M
-6.34%-979.1M
-6.21%-965.52M
-6.21%-965.52M
-5.49%-950M
-5.12%-937.3M
-5.11%-920.77M
Paid-in capital
1.33%1.16B
1.33%1.16B
1.56%1.15B
1.60%1.15B
1.72%1.15B
1.68%1.14B
1.68%1.14B
-0.99%1.14B
-3.51%1.13B
-9.69%1.13B
Gains losses not affecting retained earnings
771.43%61K
771.43%61K
-36.00%32K
54.55%-10K
--0
110.77%7K
110.77%7K
122.22%50K
92.31%-22K
-180.39%-41K
Total stockholders'equity
69.03%296.72M
69.03%296.72M
25.33%232.68M
16.09%224.85M
-18.98%165.98M
-17.58%175.55M
-17.58%175.55M
-24.57%185.65M
-30.87%193.69M
-44.71%204.87M
Total equity
69.03%296.72M
69.03%296.72M
25.33%232.68M
16.09%224.85M
-18.98%165.98M
-17.58%175.55M
-17.58%175.55M
-24.57%185.65M
-30.87%193.69M
-44.71%204.87M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 256.94%315.36M256.94%315.36M260.85%329.68M252.63%338.8M30.89%130.86M-13.74%88.35M-13.74%88.35M-31.82%91.36M-42.62%96.08M-58.56%99.98M
-Cash and cash equivalents 343.97%167.81M343.97%167.81M647.60%174.77M508.32%281.93M105.47%110.61M-4.42%37.8M-4.42%37.8M-67.39%23.38M-56.11%46.35M-71.31%53.84M
-Short-term investments 191.87%147.55M191.87%147.55M127.86%154.91M14.36%56.88M-56.13%20.24M-19.61%50.55M-19.61%50.55M9.09%67.98M-19.60%49.73M-13.91%46.14M
Receivables 39.60%95.54M39.60%95.54M8.44%18.27M53.29%21.92M4.70%15.35M291.67%68.44M291.67%68.44M-1.24%16.85M-9.48%14.3M19.51%14.66M
-Accounts receivable 146.96%45.54M146.96%45.54M8.44%18.27M53.29%21.92M4.70%15.35M5.53%18.44M5.53%18.44M-1.24%16.85M-9.48%14.3M19.51%14.66M
-Other receivables 0.00%50M0.00%50M--------------50M--50M------------
Prepaid assets ---------------------96.42%73K-96.42%73K-63.46%597K170.28%2.65M36.88%2.09M
Other current assets 76.85%7.56M76.85%7.56M-12.08%6.75M-11.35%5.57M-46.41%4.06M-63.14%4.28M-63.14%4.28M-14.66%7.68M-19.20%6.28M20.51%7.57M
Total current assets 159.80%418.46M159.80%418.46M204.51%354.7M207.02%366.29M20.89%150.26M20.61%161.07M20.61%161.07M-27.96%116.48M-37.86%119.31M-52.44%124.29M
Non current assets
Net PPE -15.39%30.27M-15.39%30.27M-14.59%31.71M-17.08%33.13M-21.83%34.46M-21.13%35.77M-21.13%35.77M-20.79%37.12M-16.77%39.96M-14.08%44.08M
-Gross PPE -7.02%54.09M-7.02%54.09M-14.59%31.71M-17.08%33.13M-21.83%34.46M-13.09%58.17M-13.09%58.17M-20.79%37.12M-16.77%39.96M-14.08%44.08M
-Accumulated depreciation -6.34%-23.82M-6.34%-23.82M-------------3.79%-22.4M-3.79%-22.4M------------
Investments and advances --11.13M--11.13M--3.03M----------0--0------------
Other non current assets -83.65%25.72M-83.65%25.72M-87.15%26.03M-86.88%26.61M-21.72%158.86M-22.54%157.32M-22.54%157.32M-1.24%202.5M-1.87%202.77M-2.03%202.93M
Total non current assets -65.24%67.11M-65.24%67.11M-74.64%60.76M-75.39%59.74M-21.74%193.32M-22.28%193.09M-22.28%193.09M-4.87%239.63M-4.68%242.72M-10.89%247.01M
Total assets 37.10%485.57M37.10%485.57M16.67%415.46M17.68%426.04M-7.47%343.58M-7.29%354.16M-7.29%354.16M-13.90%356.11M-18.94%362.03M-31.05%371.31M
Liabilities
Current liabilities
Payables -2.96%7.86M-2.96%7.86M-20.86%6.29M247.51%28.37M1.04%8.26M1.01%8.1M1.01%8.1M235.47%7.94M420.33%8.16M207.02%8.18M
-accounts payable 14.54%2.57M14.54%2.57M52.20%2.21M0.06%1.68M42.82%2.41M47.11%2.24M47.11%2.24M-38.60%1.45M6.69%1.67M-36.69%1.69M
-Total tax payable -9.67%5.29M-9.67%5.29M--4.07M--26.7M--5.85M--5.85M--5.85M------------
-Other payable ------------------------------6.49M--6.49M--6.49M
Current accrued expenses 46.87%19.5M46.87%19.5M78.89%20.21M45.47%15.37M31.95%12.43M3.49%13.28M3.49%13.28M-14.84%11.3M-23.42%10.56M-41.35%9.42M
Current debt and capital lease obligation 2.18%10.95M2.18%10.95M160.10%10.91M158.26%10.9M165.99%10.81M173.06%10.71M173.06%10.71M-56.80%4.2M-53.94%4.22M-45.32%4.06M
-Current capital lease obligation 2.18%10.95M2.18%10.95M160.10%10.91M158.26%10.9M165.99%10.81M173.06%10.71M173.06%10.71M-56.80%4.2M-53.94%4.22M-45.32%4.06M
Current liabilities 19.38%38.3M19.38%38.3M59.62%37.41M138.09%54.63M45.43%31.5M29.55%32.09M29.55%32.09M-7.62%23.44M-6.52%22.95M-17.27%21.66M
Non current liabilities
Long term debt and capital lease obligation -18.79%31.76M-18.79%31.76M-17.42%33.68M-16.21%35.56M-14.81%37.35M-13.55%39.11M-13.55%39.11M-0.81%40.79M-0.19%42.44M0.18%43.84M
-Long term capital lease obligation -18.79%31.76M-18.79%31.76M-17.42%33.68M-16.21%35.56M-14.81%37.35M-13.55%39.11M-13.55%39.11M-0.81%40.79M-0.19%42.44M0.18%43.84M
Other non current liabilities 2.74%33.11M2.74%33.11M-6.18%32.53M-2.23%33.19M-4.72%32.26M-4.40%32.22M-4.40%32.22M-0.51%34.67M-0.84%33.95M0.58%33.86M
Total non current liabilities 2.74%150.55M2.74%150.55M-1.12%145.37M0.80%146.55M0.91%146.1M1.59%146.53M1.59%146.53M3.47%147.02M2.45%145.39M2.09%144.78M
Total liabilities 5.73%188.85M5.73%188.85M7.23%182.78M19.51%201.19M6.71%177.6M5.69%178.62M5.69%178.62M1.79%170.45M1.12%168.34M-0.92%166.44M
Shareholders'equity
Share capital --1K--1K--1K--1K--1K--0--0--0--0--0
-common stock --1K--1K--1K--1K--1K--0--0--0--0--0
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings 10.97%-859.63M10.97%-859.63M3.09%-920.65M1.39%-924.27M-6.34%-979.1M-6.21%-965.52M-6.21%-965.52M-5.49%-950M-5.12%-937.3M-5.11%-920.77M
Paid-in capital 1.33%1.16B1.33%1.16B1.56%1.15B1.60%1.15B1.72%1.15B1.68%1.14B1.68%1.14B-0.99%1.14B-3.51%1.13B-9.69%1.13B
Gains losses not affecting retained earnings 771.43%61K771.43%61K-36.00%32K54.55%-10K--0110.77%7K110.77%7K122.22%50K92.31%-22K-180.39%-41K
Total stockholders'equity 69.03%296.72M69.03%296.72M25.33%232.68M16.09%224.85M-18.98%165.98M-17.58%175.55M-17.58%175.55M-24.57%185.65M-30.87%193.69M-44.71%204.87M
Total equity 69.03%296.72M69.03%296.72M25.33%232.68M16.09%224.85M-18.98%165.98M-17.58%175.55M-17.58%175.55M-24.57%185.65M-30.87%193.69M-44.71%204.87M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More